[{"Assets_0_Q2_USD":2716411000.0,"CommonStockSharesOutstanding_0_Q2_shares":111114000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":100185000.0,"NetIncomeLoss_1_Q2_USD":-219481000.0,"NetIncomeLoss_2_Q2_USD":-401396000.0,"StockholdersEquity_0_Q2_USD":1757195000.0,"Ticker":"ALNY","CIK":"1178670","name":"ALNYLAM PHARMACEUTICALS, INC.","OfficialName":"Alnylam Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"19459816074.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190806"}]